Comparison

AtlasRx vs TapReports

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

AtlasRx

This business tool optimizes pharmaceutical sales routes and schedules daily call itineraries. It allows reps to track progress, record appointment details, and manage work travel. Access requires organizational authorization.

Highlights
  • Optimized call itineraries
  • Daily schedule generation
  • Progress tracking
  • Appointment information logging
  • Work travel management
  • Target list integration
Read full description

Make more calls and maximize your field effectiveness with AtlasRx, the first routing app built exclusively for the pharmaceutical sales industry. AtlasRx displays daily call itineraries generated by proprietary algorithms based on each sales rep's target list. Track your progress throughout the day and capture important information about appointments, practice locations, and work travel. WHAT YOU GET - Daily call itineraries built automatically from your target list - Directions to every stop on the day's route - Progress tracking as you work through your calls - Notes on providers, practice locations, and appointments - Appointments, work travel, and time off handled inside your schedule SUBSCRIPTION AtlasRx requires a subscription. - AtlasRx Monthly - $24.99 per month, including a 1-month free trial for new subscribers - AtlasRx Annual - $199.99 per year Sign up with a 1 month free trial! The free trial converts to a paid monthly subscription unless you cancel at least 24 hours before it ends. Payment is charged to your Apple Account at confirmation of purchase. Subscriptions renew automatically at the same price and period unless auto-renew is turned off at least 24 hours before the end of the current period. You can manage your subscription and turn off auto-renew in your Apple Account settings after purchase. Terms of Use (EULA): https://atlasroutes.com/terms-of-service Privacy Policy: https://atlasroutes.com/terms-of-service Questions? Email info@atlasroutes.com or visit https://www.atlasroutes.com

About

TapReports

Access and monitor your TapClicks dashboards and reports on the go. View data in various formats, adjust date ranges, and schedule reports to be delivered directly to your inbox. Organize your favorite dashboards for quick access and make data-driven decisions from anywhere.

Highlights
  • Mobile dashboard access
  • Report viewing and scheduling
  • Date range adjustment
  • Favorite dashboards organization
  • Executive summary review
  • Scheduled report delivery
Features
Read full description

Introducing the TapClicks Reporting companion app– your mobile solution for monitoring your dashboard and reports from the TapClicks platform allowing you mobile access to your TapClicks Reporting dashboard and Report Studio reports. View dashboards in list or tile formats, adjust date ranges, review executive summaries and schedule reports right from the mobile experience. Organize your dashboards with “All” and “Favorites” tabs, download detailed reports, and stay on top of your data with scheduled reports s delivered straight to your inbox. Designed for marketers, agencies, and businesses, TapClicks provides everything you need to make data-driven decisions anytime, anywhere.

Screenshots

AtlasRx4 screens
TapReports4 screens

Verdict

The call

The clearest difference is in-app purchases: TapReports at none against AtlasRx's 2. TapReports also leads on iOS requirement (12.0 vs 15.2). AtlasRx's advantage is update cadence (every 3 weeks vs every 2 months) and ratings volume (7 vs 1). On price, rating, ads and monetization model there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. AtlasRx sells 2 in-app purchases, starting at $24.99 per month. TapReports asks for nothing beyond the download.

ReceptionRating · Positive reviews · Number of ratings

On the App Store both sit at effectively the same score — 5.0 for AtlasRx against 5.0 for TapReports. That said, the two scores are not equally well evidenced: AtlasRx has 7 ratings behind it against 1, so its average is the more settled of the two.

UpkeepUpdate frequency

AtlasRx ships an update every 3 weeks, TapReports every 2 months. The most recent releases landed on October 24, 2026 and October 21, 2026 respectively.

Scorecard4 real differences · 6 level
AtlasRx versus TapReports: the parameters behind the verdict, then further details
ParameterAtlasRxTapReports
PriceFreeFree
Rating5.0 (7 ratings)5.0 (1 ratings)
Positive reviews100.0% of reviews—
Number of ratings7 — better1
Update frequencyEvery 3 weeks — betterEvery 2 months
AdsNoNo
In-app purchasesYesNo — better
MonetizationFreeFree
DevicesiPhone, iPad, iPod — betteriPhone, iPod
Requires iOS15.212.0 — better
Further details — not scored
Size44 MB61 MB
Age rating4+4+
DeveloperAtlas Routes, IncTapClicks, Inc.

Customer experience

AtlasRx

All ratings7 ratings
Positive100.0%
Neutral0.0%
Negative0.0%
Written reviews4 reviews
Positive100.0%
Neutral0.0%
Negative0.0%

TapReports

All ratings1 ratings
Positive100.0%
Neutral0.0%
Negative0.0%

In-app purchases

2 purchases

AtlasRx

Subscriptions2
  • Monthly Plan1 Month trial$24.991 Month
  • Annual Plan$199.991 Year
None

TapReports

No in-app purchases

Questions

Is AtlasRx free?
AtlasRx is free to download, with in-app purchases available.
Is TapReports free?
TapReports is free to download, with no in-app purchases.
Which has better reviews, AtlasRx or TapReports?
AtlasRx and TapReports are both rated 5.0 out of 5 on the App Store, from 7 and 1 ratings respectively.
Do AtlasRx or TapReports have ads?
Neither AtlasRx nor TapReports shows ads.
Which is updated more often, AtlasRx or TapReports?
AtlasRx ships an update every 3 weeks, and TapReports every 2 months. Most recently, AtlasRx was updated on October 24, 2026 and TapReports on October 21, 2026.

Other comparisons